Leqvio®
Leqvio® (inclisiran) The liver plays a key role in clearing bad cholesterol (LDL-C) from the blood, but certain proteins in the liver can interfere with this process. LEQVIO uses the body’s natural processes to prevent many of these proteins from forming in the first place, cutting down bad cholesterol for up to 6 months per injection, after the two initial doses.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Novartis |
CLASS: Small interfering RNAs (siRNAs) |
WHAT IT TREATS: Cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia |
PRESCRIBED BY: Various |
HOW ADMINISTERED: Injection |
FREQUENCY: Initially, again at 3 months, and then every 6 months |
Length of infusion: |
FOR MORE INFORMATION: |
